References
- Institute of Medicine, Division of Health Promotion and Disease Prevention. The impact of prenatal care. In: Preventing low birthweight. Washington, DC: Natl Academy Press. 1985: 18–20
- Sepe SJ, Connell FA, Geiss LS, et al. Gestational diabetes: Incidence, maternal characteristics, and perinatal outcome. Diabetes 1985: 34(Suppl 2): 13–6
- Centers for Disease Control. Public health guidelines for enhancing diabetes control through maternal-and child-health programs. MMWR 1986: 35(13): 201–8.213
- Stowers JM, Sutherland HW, Kerridge DF. Longrange implications for the mother: the Aberdeen experience. Diabetes 1985: 34(Suppl 2): 106–10
- Nelson RL. Diabetes and pregnancy. Primary Care 1983: 10(2): 225–40
- Scherger JE, Hudson W. Routine screening for gestational diabetes reconsidered. (Editorial) J Fam Pract 1985: 21(3): 177–8
- Centers for Disease Control. Recommendations for protection against viral hepatitis. MMWR 1985: 34(22): 313–24,329–35
- Delaplane D, Yogev R, Crustd F, et al. Fatal hepatitis B in early Infancy: the importance of identifying HBsAg-positive pregnant women and providing immunoprophylaxis to their newborns. Pediatrics 1983: 72(2): 176–80
- Thompson SE, Washington AE. Epidemiology of sexually transmitted Chlamydia trachomatis infections. Epidemiol Rev 1983: 5: 96–123
- Centers for Disease Control. Chlamydia trachomatis infections: policy guidelines for prevention and control. MMWR 1985: 34(Suppl 3): 53–74S
- Schachter J, Grossman M, Sweet RL, et al. Prospective study of perinatal transmission of Chlamydia trachomatis. JAMA 1986: 255(24): 3374–7
- Tarn MR, Stamm WE, Handsfield HH, et al. Culture-independent diagnosis of Chlamydia trachomatis using monoclonal antibodies. N Engl J Med 1984: 310(18): 1146–50
- Centers for Disease Control. Update: acquired Immunodeficiency syndrome—United States. MMWR 1986: 35(49): 757–60.765–6
- Centers for Disease Control. Recommendations for assisting In the prevention of perinatal transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus and acquired immunodeficiency syndrome. MMWR 1985: 34(48): 721–6,731–2
- Scott GB, Fischl MA, Klimas N, et al. Mothers of infants with the acquired immunodeficiency syndrome: evidence for both symptomatic and asymptomatic carriers. JAMA 1985: 253(3): 363–6
- Centers for Disease Control. Recommendations for prevention of HIV transmission in health-care settings. MMWR 1987: 36(Suppl 2): 1–18S
- Schwager EJ, Weiss BD. Prenatal testing for maternal serum alpha-fetoprotein. Am Fam Physician 1987: 35(4): 169–74
- American College of Obstetricians and Gynecologists, Department of Professional Liability. Professional liability implications of AFP tests. DPL Alert 1985: (May)
- Milunsky A, Alpert E. Results and benefits of a maternal serum alpha-fetoprotein screening program. JAMA 1984: 252(11): 1438–42
- DiMaio MS, Baumgarten A, Greenstein RM, et al. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels. N Engl J Med 1987: 317(6): 342–6